Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP676734.RA0sNjPhRQ6cFcQ_MwZPJAK6qrNTfQ4JX_EJo2CN7lYrA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP676734.RA0sNjPhRQ6cFcQ_MwZPJAK6qrNTfQ4JX_EJo2CN7lYrA130_assertion type Assertion NP676734.RA0sNjPhRQ6cFcQ_MwZPJAK6qrNTfQ4JX_EJo2CN7lYrA130_head.
- NP676734.RA0sNjPhRQ6cFcQ_MwZPJAK6qrNTfQ4JX_EJo2CN7lYrA130_assertion description "[Using semiquantitative conventional reverse transcriptase polymerase chain reaction (RT-PCR), quantitative real-time RT-PCR, in situ hybridization and immunostaining, we evaluated the expression and the distribution of retinoic acid receptor alpha, beta, gamma, retinoid X receptor alpha, beta, gamma, thyroid hormone receptor alpha, beta, and alcohol dehydrogenase3 (a well-characterized retinoic acid responsive gene) in malignant and non-malignant tissues obtained from patients with non-small cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP676734.RA0sNjPhRQ6cFcQ_MwZPJAK6qrNTfQ4JX_EJo2CN7lYrA130_provenance.
- NP676734.RA0sNjPhRQ6cFcQ_MwZPJAK6qrNTfQ4JX_EJo2CN7lYrA130_assertion evidence source_evidence_literature NP676734.RA0sNjPhRQ6cFcQ_MwZPJAK6qrNTfQ4JX_EJo2CN7lYrA130_provenance.
- NP676734.RA0sNjPhRQ6cFcQ_MwZPJAK6qrNTfQ4JX_EJo2CN7lYrA130_assertion SIO_000772 12911822 NP676734.RA0sNjPhRQ6cFcQ_MwZPJAK6qrNTfQ4JX_EJo2CN7lYrA130_provenance.
- NP676734.RA0sNjPhRQ6cFcQ_MwZPJAK6qrNTfQ4JX_EJo2CN7lYrA130_assertion wasDerivedFrom befree-20150227 NP676734.RA0sNjPhRQ6cFcQ_MwZPJAK6qrNTfQ4JX_EJo2CN7lYrA130_provenance.
- NP676734.RA0sNjPhRQ6cFcQ_MwZPJAK6qrNTfQ4JX_EJo2CN7lYrA130_assertion wasGeneratedBy ECO_0000203 NP676734.RA0sNjPhRQ6cFcQ_MwZPJAK6qrNTfQ4JX_EJo2CN7lYrA130_provenance.